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doi:10.1016/j.gmbhs.2012.04.014Abstract Hepatitis B virus plays an important role in persistent inflammation with necrosis of
the liver tissue, with the result that some patients with hepatitis develop diabetes. The present
study aims to understand the correlation between pro-inflammatory interleukin-6 (IL-6) expres-
sion and insulin resistance in hepatitis B patients. Forty-three patients with diabetes, 68
patients with hepatitis, and 68 controls without diabetes and hepatitis were included in this
study. The concentrations of glycated hemoglobin, glucose, and insulin antibodies in patients
with hepatitis B and diabetes were significantly higher than those in controls without hepatitis
and diabetes (p < 0.001). The IL-6 concentrations in the patients with hepatitis B were signif-
icantly higher than those in the group with diabetes and the control group. The results suggest
that an increase in IL-6 level in hepatitis B patients may lead to the occurrence of high blood
glucose levels.
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Hepatitis B is the major cause of liver disease in adults over
the age of 40 years in Taiwan. The literature indicates that
hepatitis B virus plays an important role in persistent
inflammation with necrosis of the liver tissue, with the
result that some patients with hepatitis develop a liver-
derived diabetes.1 Several studies have reported that the
activities of pro-inflammatory hormones such as tumor
necrosis alpha and interleukin-6 (IL-6) are correlated with
the presence of insulin resistance, which is the importantFigure 1 Concentrations of (A) glycated hemoglobin, (B)
glucose, and (C) insulin antibodies in patients with hepatitis
(HBV) or with diabetes (DM), which were higher than those in
controls (CON) without hepatitis and diabetes, showing highly
significant differences. ** p < 0.01, *** p < 0.001.feature of type 2 diabetes.1e3 In order to understand the
correlation between proinflammatory IL-6 expression and
insulin resistance in hepatitis B patients, groups of patients
with hepatitis B and with diabetes were included in this
study.3 Hopefully, the results of the present study will
provide a reference for medical personnel to apply follow-
up medical services for patients with hepatitis B.Materials and methods
Blood samples were collected from 43 patients with dia-
betes, 68 patients with hepatitis B, and 68 randomized
controlled patients without diabetes and hepatitis, whose
medical histories were confirmed by the gastroenterologist
and endocrinologist and signed letters of informed consent.
Analysis of the concentrationsof glucose, glycated hemo-
globin (HbA1c), insulin antibodies, and IL-6 were performed
using automated equipment, the Roche Cobas C501, Perkin
Elmer 1470, and Thermo Scientific Multiskan Spectrum
(Thermo Fisher Scientific Inc. Bohemia, NY, USA), respec-
tively, according to the manufacturers’ protocols. The
values for each test were analyzed by Student t test to
compare the results and determine the difference of
degree between them.Results
The concentrations of HbA1c, glucose, and insulin anti-
bodies in 68 patients with hepatitis B (6.5  1.6%,
103  39 mg/dL, and 6.43  1.2%, respectively) and 43
patients with diabetes (7.0  1.1%, 122  32 mg/dL, and
6.39  1.3%,respectively) were higher than those of
randomized controlled patients without hepatitis and
diabetes (5.6  0.3%, 88  19 mg/dL, and 5.73  0.54%,
respectively), the difference being highly significant
(p < 0.001; Fig. 1). In line with these findings, IL-6
concentrations in the patients with hepatitis B (0.0077 
0.0149 ng/mL) and with diabetes (0.0012  0.0076 ng/mL)
were also higher than that in the control group
(0.0006  0.0042 ng/mL), a significant difference beingFigure 2 Concentration of interleukin-6 in hepatitis B
patients (HBV), which was significantly higher than that in the
diabetes (DM) and control (CON) groups. * p < 0.05.
IL-6 in patients with hepatitis B and hyperglycemia 67seen only between the patients with hepatitis and the
control group (p < 0.05; Fig. 2).Discussion and conclusion
The reason for hepatitis patients developing high blood
glucose levels is not well understood. In the present study,
blood glucose, IL-6, and insulin antibodies were shown to
increase in hepatitis B patients, which suggested that
infection with hepatitis B virus is also an important cause of
high blood glucose. Therefore, further studies of gene
expression are needed to investigate whether the above
biomarkers could be used in hepatitis B patients as
predictors of the occurrence of high blood glucose levels,
optimal medical services then being targeted toward this
group.Acknowledgments
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